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INTRODUCTION
Expanded polytetrafluoroethylene (ePTFE) vas-
cular grafts are widely acknowledged as the most
reliable synthetic arterial substitutes in the treatment
of lower-extremity ischaemia.1–4 However, the
diminished patency rate of these grafts has been
reported to jeopardize the distal blood supply in
patients.2–4 Because of the morphological structure
and chemical nature of ePTFE grafts, the implants
exhibit a negative host response that is generally
associated with the formation of a significant fibrous
capsule, the presence of cells (eg, monocytes and
macrophages), and acute endothelial and smooth
muscle cell migration and proliferation culminating
in anastomotic stenosis.5–10 Thus experimental and
clinical observations have associated synthetic graft
failure with their thrombotic threshold velocity,11
which appears to be intimately related to intimal
hyperplasia at anastomotic sites and to an athero-
sclerotic process.8–11
In previous studies on tissues developed within
vascular prostheses, graft failure with ePTFE has
been associated with the progression of atheroscle-
rotic disease.12 In addition, according to Walton et
al,13 a phenomenon indistinguishable from “true”
atherosclerosis was observed in 39 peripherally locat-
ed synthetic arterial prostheses removed from 38
patients after periods ranging from 2 months to 18
years. Lipid deposition has been known to occur in
the reactive tissue ensheathing the various plastic
grafts, as it increased according to the age of grafts,
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was independent of the nature of the plastic fibers,
and contributed to graft failure. In fact, the immuno-
histology of the lipid-filled lesions demonstrated
characteristic features of an atherosclerosis-like trans-
formation. Some years later, Chignier et al14 showed
that lipids may be trapped within the pseudointima of
synthetic vascular grafts, therefore contributing to
prosthesis failure. The quantitative analysis of the tis-
sular lipid composition demonstrated that the total
amount of lipids was more extensive in synthetic vas-
cular grafts than in native control arteries.
Moreover, our group has demonstrated that lipid
retention occurred on both surfaces of 367 ePTFE
vascular prostheses explanted from humans during
the early stages of implantation and depended on the
time of implantation, the sex of the patients, and the
prostheses’ morphological parameters, including
diameter.15,16 In addition, some changes in the sur-
face composition of ePTFE arterial prostheses
explanted from humans have been observed, and
these changes are associated with lipid uptake.17
Thus the lipid uptake occurs when the lipid reten-
tion within the prosthesis structure is greater than
the rate of transport through the prosthesis wall.
Optimization of conditions in the healing process
and the development of a truly biocompatible vas-
cular graft will warrant an in-depth knowledge of the
molecular mobility and the lipid uptake phenome-
non, both of which appear to affect the performance
of the prosthesis.
A lipid uptake model in ePTFE arterial prosthe-
ses was proposed through in vitro experiments to
determine the lipid concentration on the luminal
and external surface of an ePTFE arterial prosthesis
in contact with a lipid dispersion for various periods
of exposure, flow rates, and pressure conditions.
Particular attention was given to studying the effect
of time on the permeability of these ePTFE arterial
prostheses.
MATERIALS AND METHODS
Graft selection. An expanded polytetrafluo-
roethylene (ePTFE) arterial prosthesis from Baxter
Health Care Co (Laguna Hills, CA) was selected. A
thin Teflon layer reinforcing the porous PTFE struc-
ture covered the external surface of the prosthesis.
The structure of the graft was characterized by the
presence of nodules, aligned perpendicularly to the
blood flow and interlinked by smaller fibrils
(Vermette P, unpublished observations). The pros-
thesis had an internal diameter of 10.70 ± 0.04 mm,
a wall thickness of 0.83 ± 0.01 mm, and a porosity
of 69% ± 1%.
Fluid. A 2.5% (wt/wt) lipid suspension was
made by mixing appropriate amounts of phos-
phatidylcholine (PC) from fresh-frozen egg yolk (P-
9671, Sigma Chemical Co, St. Louis, MO) in double-
distilled water. Although higher than the lipid con-
centration observed in whole blood, which has a total
lipid concentration of approximately 0.6% (wt/wt),18
this particular lipid concentration was chosen because
the viscosity of this dispersion closely matched that of
blood in identical flow conditions.19
A phospholipid dispersion was selected as the
model fluid because these lipids were present in a
significant proportion in the total lipid concentra-
tion of the whole blood and because of the impor-
tant role these lipids have in the coagulation cas-
cade.20 Phosphatidylcholine was chosen because it is
one of the most abundant lipids found in the extra-
cellular membrane of platelets and red blood cells.20
It has been pointed out that phosphatidylcholine-
based lipids, combined with cholesterol, play a major
role in the progression of atherosclerosis leading to
endothelial dysfunction.21–24
Water permeability. Water permeability tests
were carried out with double-distilled water at 37°C
under dynamic flow conditions, using a system
described by Vermette et al.25 For physiological rea-
sons, water permeability tests under dynamic flow
conditions were preferred to those under static con-
ditions. The tests were performed at a flow rate of
2000 mL/min at hydrostatic pressures of 80, 120,
180, and 300 mm Hg and at the maximum pressure
required for the water to percolate immediately
through the prosthesis membrane. The time it took
the water to percolate through the prosthesis wall
was recorded for each pressure. The effect of time
on the permeability for the prosthesis exposed to a
pressure of 180 mm Hg and for the prosthesis
exposed to a pressure of 300 mm Hg was recorded
by collecting the water volume that percolated
through the prosthesis wall for a given period.
Lipid uptake. A prosthesis 5 cm long was
clamped in a flow circulation system, developed in
our laboratory25 to replicate some of the physiolog-
ical conditions of transmural pressure and flow rate
with the model fluid mentioned above. The graft
was located inside a closed reservoir containing dou-
ble-distilled water, and the temperature of the entire
system was maintained at 37°C. We focused on 3
operating variables of clinical relevance: flow rate,
transmural pressure, and length of exposure of the
prosthesis to the PC dispersion. Table I shows the
mode and range of operation used for each variable.
After submitting the prosthesis to the conditions
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listed in Table I, and before performing any charac-
terization, each prosthesis sample was rinsed in dou-
ble-distilled water for 1 hour to remove any
unbound lipids on both surfaces.
Scanning electron microscopy and light
reflected microscopy. In order to characterize the
effect of the lipid uptake on the microstructure of
the prosthesis and identifying the presence of lipids,
the luminal surface of the prosthesis exposed to the
PC suspension was examined under a scanning elec-
tron microscope (SEM). The specimens were first
fixed with osmium tetroxide (OsO4) to unsolubilize
the lipids, then they were dried and coated with gold
for observation under a SEM (JSM-35CF, Jeol,
Peabody, MA) at an accelerating voltage of 15 kV. In
addition, by cutting a slice 5 m m thick and fixing it
on a microscope slide (as previously published26),
the structure of a virgin prosthesis was observed in
the longitudinal axis using a reflected light micro-
scope (Axioplan, Zeiss, Germany) at a magnification
of 5· .
Fourier transform infrared spectroscopy. The
surface lipid concentration was probed at 6 selected
locations (2 in the proximal region, 2 in the center,
and 2 in the distal region), using a Fourier transform
infrared spectrometer (FT-IR) equipped with a
MCT (Mercury Cadmium Telluride)/A detector
and a germanium-coated KBr beam splitter (Nicolet
Instrument, Madison, WI), on the luminal and
external surfaces of the prosthesis. As the surface
characterization was targeted, the spectra were
recorded in the attenuated total reflectance mode
(ATR) using a split pea attachment equipped with a
hemispherical silicon crystal 3 mm in diameter
(Harrick Co, Ossining, NY), collecting 100 scans
with a 4 cm-1 resolution. To properly characterize
the lipid concentration, a lipid concentration index
(LCI) was defined to take into account the porosity
of the ePTFE.15,16 Indeed, the ePTFE prosthesis
registered a high porosity index, and the results were
influenced by the fraction of the porosity in the
observation window. The LCI corresponds to the
lipid concentration in the area observed, normalized
to the fraction of the surface occupied by the ePTFE
membrane. The LCI was therefore calculated by
dividing the area under the infrared peaks between
2700 and 3100 cm-1, where features caused by the
stretching modes of methylene and methyl groups of
lipids appeared, and the area ranging from 800 to
1450 cm-1 associated with the spectral absorption
caused by the stretching modes of CF2 groups of
ePTFE.
RESULTS
Water permeability. Table II shows the time
required for the water to percolate on the outer
prosthesis wall at a flow rate of 2000 mL/min and a
temperature of 37°C, under various hydrostatic
pressures. Under pressures of 80 mm Hg and 120
mm Hg, no water was observed on the outer surface
of the membrane after 72 hours. Under pressures of
180 mm Hg and 300 mm Hg, small drops of water
began to appear on the outer wall of the membrane
after an exposure of 720 minutes and 75 minutes,
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Table I. Parameters simulating the lipid uptake (37°C with the phosphatidylcholine suspension).
Operating variables Time of exposure (hours) Transmural pressure (mm Hg) Flow rate (mL/min)






Transmural pressure 4 80 2000
4 180 2000
4 80–180 (f = 1 Hz) 2000
Flow rate 4 80 500
4 80 2000
Table II. Percolating time for water through the
prosthesis membrane under a flow rate of 2000
mL/min, a temperature of 37°C, and various trans-
mural pressures.
Transmural pressure (mm Hg) Time
80 no flow after 4320 minutes
120 no flow after 4320 minutes
180 720 minutes
300 75 minutes
325 ± 5* immediately
*Triplicates.
respectively. After this permeation time, the water
flow rate through the prosthesis wall increased over
time, as shown in Fig. 1. The dependence of the
membrane permeability over time may be associated
with the dilatation and plastic deformation of the
prosthesis. When exposed to 300 mm Hg, a pressure
close to double 180 mm Hg, the permeability
increased by a factor of 1000.
Lipid uptake. Because of the pressure exerted
by the fluid flowing inside the prosthesis, fluid per-
meation occurred through the wall. Moreover, once
the membrane was wetted and the fluid had begun
to permeate the prosthesis wall, the lipid mass flux
increased rapidly to reach a maximum, then steadily
decreased until the membrane became completely
impermeable to the fluid dispersion. Phospholipids
accumulating and agglomerating within the prosthe-
sis wall gradually limited the molecular mobility
across the microporous structure, causing the flow
to stop. This behavior was further confirmed by
SEM analyses, which are presented in Fig. 2.
Fig. 3 clearly shows the movement of the PC dis-
persion across the prosthesis wall after an 8-hour
exposure to lipid dispersion at a flow rate of 2000
mL/min, a transmural pressure of 80 mm Hg, and
a temperature of 37°C. Preferential pathways of con-
vection, with almost constant periodicity across the
length of the prosthesis, were observed. The focal
pathways of molecular transport observed in Fig. 3
were in good agreement with the nonhomogeneity
in the porosity depicted in Fig. 4, in which the light-
reflected microphotograph of the longitudinal sec-
tion clearly demonstrates a significant change in
porosity. It was also possible to observe the presence
of these regularly spaced perforations in the bulk
structure of the prosthesis, when the external wrap
of the PTFE membrane was removed. McClurken et
al27 reported the presence of similar regularly fash-
ioned perforations in the structure of other ePTFE
vascular prostheses.
FT-IR ATR spectroscopy was used to monitor
the amount of lipids that were bound onto the pros-
thesis’ surfaces (Fig. 5). As shown in this figure, the
lipids tended to accumulate preferentially on the
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Fig. 1. Time dependence permeability for the prosthesis exposed to a hydrostatic pressure of
180 mm Hg and 300 mm Hg under a flow rate of 2000 mL/min at 37°C.
luminal surface. This may be associated with the
morphological structure of the PTFE wrap used by
the manufacturer to reinforce the arterial prosthesis,
which, although being somewhat permeable, has
been known to act as a barrier and self-inhibitor
toward an eventual tissue infiltration and endothelial-
ization of this graft.5 The amount of lipids found on
the luminal and external surfaces exhibited a clear
tendency over time (Fig. 5, A); LCI measured after 2
hours, 4 hours, and 24 hours of exposure remained
relatively low, and it increased considerably up to 168
hours of exposure. Surprisingly, the LCI for the pros-
thesis after 168 hours of exposure to the lipid disper-
sion decreased significantly with time. When the fluid
leakage through the membrane ceased, no further
lipid accumulation within the membrane occurred.
This behavior, as a function of time, may be
explained by lipids in direct contact with the fluid
detaching because of erosion or simple diffusion.
As Fig. 5, B, shows, no clear relation was estab-
lished between the level of pressure and the LCI.
Nevertheless, the amount of lipids retained on the
surfaces appeared to be affected by the pressure gra-
dient, because a pressure of 80 mm Hg appeared to
lead to greater lipid retention on the luminal side of
the prosthesis. Fig. 5, C, shows that no distinction
was drawn between the prosthesis exposed to a flow
rate of 500 mL/min and the prosthesis exposed to
2000 mL/min of the PC suspension. When the fluid
movement through the membrane occurred, the
molecular diffusion from the bulk of the flowing liq-
uid was negligible when compared with the convec-
tion, which explains the independence of liquid flow
rate in the prosthesis. Moreover, even when the con-
centration and composition of the model fluid dif-
fered from the concentration and composition of
whole blood, the magnitude of the lipid uptake
observed closely matched the amounts of unsaturat-
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Fig. 2. Scanning electron microscope picture, magnification · 480, of the luminal surface of
A, a virgin prosthesis compared with prostheses exposed, B, 168 hours, C, 336 hours, and D,
720 hours to the phosphatidylcholine dispersion under a transmural pressure of 80 mm Hg, a
flow rate of 2000 mL/min, and a temperature of 37°C.
ed fatty acids bound onto the ePTFE prostheses
explanted from humans.16
DISCUSSION
As stated by Chignier et al,14 the mechanism of
vascular prosthesis failure is not a single response
concerning only cellular proliferation and tissue
ingrowth, but includes a series of complex interactive
cascades among the cellular and noncellular compo-
nents within the pseudointima, eventually leading to
the atherosclerotic degenerative process, frequently
responsible for graft failure, that can be observed
even in the absence of plasma lipid disorders.
Because of the primary function of the arterial
prostheses, which is to re-establish normal blood flow
within poorly irrigated parts of the body, several
important aspects that may compromise their long-
term performance have been neglected. Among them
is the mobility of biological molecules across the wall
of the prosthesis, which is a phenomenon that has lead
to only a few studies, despite its great significance.
The results of the present study clearly indicate
that molecules may indeed move through the wall of
an ePTFE arterial prosthesis, despite its highly
hydrophobic nature. As clearly demonstrated, the
pressure exerted within the arterial prosthesis may
drive the molecules from the internal side to the
external side of the prosthesis. As pointed out by our
results, even water may percolate through the micro-
porous structure of the Teflon prosthesis under a
pressure of 180 mm Hg, which is a systolic pressure
frequently measured in patients with hypertension.
Given the evolution of the water permeability
through the prosthesis wall as a function of the
hydrostatic pressure, it is probable that, even within
physiological limits, blood pressure will act as a dri-
ving vector for the transport of biological molecules.
Because of the complex nature of blood, one
may also postulate that the interaction of some spe-
cific molecules will lead to an increase in the wetta-
bility of PTFE, similarly to what is observed when
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Fig. 3. Convection of the phosphatidylcholine dispersion through the prosthesis wall, after
exposing the graft for 8 hours to the model fluid for a flow rate of 2000 mL/min, a transmural
pressure of 80 mm Hg, and a temperature of 37°C.
Fig. 4. Light-reflected microscope picture, magnification
· 5, of the longitudinal axis of a virgin prosthesis.
FPO
microporous PTFE is immersed in organic solvents
such as ethanol or chloroform (Guidoin R, unpub-
lished observations). In addition, the permeability
tests point out that ePTFE vascular grafts may
undergo postleakage as, for example, perigraft sero-
ma formation (a collection of clear, sterile fluid),
which has been observed when using vascular pros-
theses made of PTFE.28–30 This fluid may therefore
act as a de facto wettability medium, allowing not
only its own transport through the wall of the vas-
cular prosthesis, but also that of other molecules.
It is in this context that we have focused on lipid
uptake in the wall of arterial prostheses. Indeed, it
has been pointed out in several instances that a phe-
nomenon similar to atherosclerosis is observed dur-
ing in vivo implantation of synthetic arterial prosthe-
ses.12–14 Although the effect of this atherosclerosis-
like phenomenon has not been established with
certainty, its similarities to what is observed in natur-
al arteries has raised questions about its importance
in the long-term patency rate of vascular devices.
It is clear that the structures of healthy biological
arteries and arterial prostheses differ in many
regards. Considering the transmural molecular
transport, it is well known that a healthy vascular
bed is a self-regulating medium that controls the
movement of molecular species through its wall by
its endothelial cell lining.24 On the other hand, lipid
uptake in arterial prostheses is a totally unregulated
phenomenon that occurs very rapidly15,16 and is
observed not only because of the strong affinity of
lipids for the highly hydrophobic structure of the
polymers used to manufacture the grafts.13 These
observations therefore enable us to hypothesize that
the fast kinetics of lipid retention within the pros-
thesis wall should be taken into account in the heal-
ing process and neoendothelialization of these
devices. However, this particular behavior by the
lipids is not the sole factor leading to the failure of
arterial prostheses, because one other major effect of
lipids in relation with graft failure may be related to
their implication in the coagulation cascade through
the “prothrombinase complex” (factor Xa, Va, phos-
pholipids, and Ca2+).31–33
CONCLUSION
It appears obvious that the mechanisms that take
into account the blood compatibility and biocom-
patibility of synthetic arterial prostheses are driven
by several factors that may work either alone or in
synergy. Therefore the problems related to the fail-
ure of the arterial grafts cannot be explained by a
single observation or theory. Rather, they must be
considered as a cascade of successive events, more or
less related, that all play a key role in the long-term
patency of arterial prostheses.
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